Skip to search formSkip to main contentSkip to account menu

Bexxar

National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2014
2014
The study aimed at identifying patient-specific dosimetric and nondosimetric factors predicting outcome of non-Hodgkin lymphoma… 
Review
2010
Review
2010
  • S. Goldsmith
  • Seminars in nuclear medicine
  • 2010
  • Corpus ID: 29762480
Radioimmunotherapy is a form of targeted radionuclide therapy that uses a monoclonal antibody to deliver localized radiation. It… 
2009
2009
IntroductionThe American Cancer Society estimated 66,120 new cases of non-Hodgkin lymphoma (NHL) in the USA in 2008… 
Review
2007
Review
2007
  • T. Karagiannis
  • Hellenic journal of nuclear medicine
  • 2007
  • Corpus ID: 32391781
Currently, beta-emitting radionuclides are used almost exclusively in the clinic and in clinical radioimmunotherapy studies. The… 
Review
2004
Review
2004
  • J. Vose
  • The oncologist
  • 2004
  • Corpus ID: 30482295
PURPOSE Immunotherapy using monoclonal antibodies to specifically target B cells has provided new hope to many patients with… 
2004
2004
6520 Background: A phase II, open-label, multicenter study was conducted to determine the efficacy of Bexxar therapy following… 
Review
2004
Review
2004
Tositumomab is an immunoglobulin G murine monoclonal antibody that binds to the CD20 antigen on the surface of normal and… 
Review
2002
Review
2002
  • B. Cheson
  • Current opinion in investigational drugs
  • 2002
  • Corpus ID: 7664533
Bexxar (131I tositumomab) is a radiolabeled anti-CD20 monoclonal antibody for the treatment of relapsed and refractory follicular…